Metabolic dysfunction-associated fatty liver disease: A key player in colorectal cancer development and progression

doi:10.13105/wjma.v14.i1.113789

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 14, Issue 1

This Article

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (25)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-1) series.

Item

Count

PDF

HTML

Figures (1-1)

Sum=37

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

Sum=1

Publishing Process of This Article

Item

Count

Browse

Download

Sum=2

Mar 18, 2026 (publication date) through Mar 10, 2026

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Meta-Analysis

ISSN

2308-3840

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

Copyright: ©Author(s) 2026. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See permissions. Published by Baishideng Publishing Group Inc.

World J Meta-Anal. Mar 18, 2026; 14(1): 113789
Published online Mar 18, 2026. doi: 10.13105/wjma.v14.i1.113789

Open in New Tab Full Size Figure Download Figure

Figure 1 Overview of the shared pathophysiological mechanisms between metabolic dysfunction-associated fatty liver disease and colorectal cancer. MAFLD: Metabolic dysfunction-associated fatty liver disease; CRC: Colorectal cancer; T2D: Type 2 diabetes; TLR: Toll-like receptor.

Citation: Fouad Y, Pan Z, Mostafa AM, Eslam M. Metabolic dysfunction-associated fatty liver disease: A key player in colorectal cancer development and progression. World J Meta-Anal 2026; 14(1): 113789
URL: https://www.wjgnet.com/2308-3840/full/v14/i1/113789.htm
DOI: https://dx.doi.org/10.13105/wjma.v14.i1.113789